Pulmotect's Grant - II Round

Pulmotect raised a round of funding on May 29, 2015. Investors include National Heart Lung and Blood Institute.

Pulmotect is a bio-pharmaceutical company that develops products (host-directed/pathogen-agnostic) to reduce morbidity and mortality in patients at risk of severe respiratory diseases.…

Articles about Pulmotect's Grant - II Round: